Price T Rowe Associates Inc United Therapeutics Corp Transaction History

Price T Rowe Associates Inc

  • $935 Billion
  • Q3 2025

A detailed history of Price T Rowe Associates Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 300,931 shares of UTHR stock, worth $140 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
300,931
Previous 114,502 162.82%
Holding current value
$140 Million
Previous $32.9 Million 283.4%
% of portfolio
0.01%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$274.7 - $438.75 $51.2 Million - $81.8 Million
186,429 Added 162.82%
300,931 $126 Million
Q2 2025

Aug 14, 2025
SELL
$276.47 - $328.4 $20.8 Million - $24.7 Million
-75,229 Reduced 39.65%
114,502 $32.9 Million
Q1 2025

May 14, 2025
SELL
$304.42 - $380.78 $63.4 Million - $79.3 Million
-208,151 Reduced 52.31%
189,731 $58.5 Million
Q4 2024

Feb 14, 2025
BUY
$348.66 - $410.0 $18.6 Million - $21.9 Million
53,355 Added 15.49%
397,882 $140 Million
Q3 2024

Nov 14, 2024
BUY
$311.04 - $363.55 $34.1 Million - $39.8 Million
109,611 Added 46.66%
344,527 $123 Million
Q2 2024

Aug 14, 2024
BUY
$228.26 - $319.04 $47.5 Million - $66.3 Million
207,940 Added 770.83%
234,916 $74.8 Million
Q1 2024

May 15, 2024
SELL
$210.76 - $249.51 $1.07 Million - $1.26 Million
-5,069 Reduced 15.82%
26,976 $6.2 Million
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $1.66 Million - $1.98 Million
7,704 Added 31.65%
32,045 $7.05 Million
Q3 2023

Nov 14, 2023
SELL
$211.82 - $248.24 $41,093 - $48,158
-194 Reduced 0.79%
24,341 $5.5 Million
Q2 2023

Aug 14, 2023
BUY
$205.19 - $232.99 $88,436 - $100,418
431 Added 1.79%
24,535 $5.42 Million
Q1 2023

May 15, 2023
BUY
$212.99 - $276.17 $126,942 - $164,597
596 Added 2.54%
24,104 $5.4 Million
Q4 2022

Feb 14, 2023
BUY
$205.95 - $280.43 $138,398 - $188,448
672 Added 2.94%
23,508 $6.54 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $22.4 Million - $26.8 Million
-109,938 Reduced 82.8%
22,836 $4.78 Million
Q2 2022

Aug 15, 2022
BUY
$174.81 - $241.14 $12.9 Million - $17.8 Million
73,913 Added 125.57%
132,774 $31.3 Million
Q1 2022

May 16, 2022
BUY
$166.16 - $213.96 $23,760 - $30,596
143 Added 0.24%
58,861 $10.6 Million
Q4 2021

Feb 14, 2022
SELL
$184.32 - $216.08 $279,429 - $327,577
-1,516 Reduced 2.52%
58,718 $12.7 Million
Q3 2021

Nov 15, 2021
SELL
$179.86 - $214.88 $183,637 - $219,392
-1,021 Reduced 1.67%
60,234 $11.1 Million
Q2 2021

Aug 16, 2021
SELL
$170.47 - $211.93 $49.9 Million - $62.1 Million
-292,869 Reduced 82.7%
61,255 $11 Million
Q1 2021

May 17, 2021
BUY
$153.94 - $174.85 $17 Million - $19.3 Million
110,623 Added 45.43%
354,124 $59.2 Million
Q4 2020

Feb 16, 2021
BUY
$101.87 - $151.79 $24.8 Million - $37 Million
243,501 New
243,501 $37 Million

Others Institutions Holding UTHR

# of Institutions
802
Shares Held
41.4M
Call Options Held
1.56M
Put Options Held
2.86M
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $21.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email